- Presentations
- 2
- Markets
- 1
Emrelis is a brand of Telisotuzumab vedotin marketed by AbbVie, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Telisotuzumab vedotin
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 100 mg/mL powder for injection, 20 mg/mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Emrelis 100 mg/mL powder for injectionIntravenous Cold chain | AbbVie | US FDA | Available on request |
| Emrelis 20 mg/mL powder for injectionIntravenous Cold chain | AbbVie | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Emrelis
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.